The FDA has addressed the shortage of Eli Lilly's weight-loss drug and a lawsuit involving compounding pharmacies. Novo Nordisk's weight-loss drug remains in short supply.
Vertex Pharmaceuticals' non-opioid drug, suzetrigine, showed little difference versus a placebo in reducing pain for lumbosacral radiculopathy, prompting FDA review for treating moderate-to-severe acute pain.
The U.S. Food and Drug Administration (FDA) recently approved remestemcel-L-rknd (Ryoncil), an allogeneic bone marrow–derived mesenchymal stromal cell therapy for steroid-refractory acute graft-vs-hos...
The regulation requires qualifying foods to contain amounts from at least one food group or subgroup referenced in the Dietary Guidelines for Americans.
Vertex Pharmaceuticals' non-opioid drug demonstrated pain reduction in patients with lumbosacral radiculopathy but fell short of investor expectations, signaling continued interest in non-opioid treatment amid the opioid epidemic.
Reuters
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The FDA has issued a 'most serious' classification for the recall of Boston Scientific's catheters used in minimally invasive surgery, linked to reports of esophageal injury and fatalities.
"Unfortunately, when we reviewed the latest evidence, we found that taking vitamin D with or without calcium does not prevent falls or fractures in older adults."
The U.S. reports its first severe human case of bird flu, impacting dairy herds and farm workers. California declares an emergency over the H5N1 virus as it spreads more widely and infects dozens of workers.
In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.